Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.
Press releases published on July 23, 2025
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
GlobeNewswire
·
July 23, 2025
Vancouver, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at its …
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
GlobeNewswire
·
July 23, 2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
GlobeNewswire
·
July 23, 2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously …
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
GlobeNewswire
·
July 23, 2025
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously published estimates1 (3.9 per 100,000), which equates to …
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. …
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today …
Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025
GlobeNewswire
·
July 23, 2025
REHOVOT, Israel, July 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
La Production de Silice Pyrogénée à L’échelle Pilote d’HPQ Approche la Viabilité Commerciale
GlobeNewswire
·
July 23, 2025
MONTRÉAL, 23 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique axée sur l’innovation dans le développement de matériaux avancés et de procédés critiques, a le …
HPQ’s Pilot-Scale Fumed Silica Production Nears Commercial Viability
GlobeNewswire
·
July 23, 2025
MONTREAL, July 23, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to update shareholders on …
Synervest Group Raises $4 Million Series A to Accelerate Global Expansion of Institutional Fintech Infrastructure
GlobeNewswire
·
July 23, 2025
ABU DHABI, United Arab Emirates, July 23, 2025 (GLOBE NEWSWIRE) -- Global Market—Synervest Group, a fintech holding company delivering institutional-grade infrastructure across trading, payments, and financial technology, today announced it has raised $4 …
UPDATE -- HT Vet Survey Reveals HT Vista’s Ability to Increase Revenue for Veterinary Clinics
GlobeNewswire
·
July 23, 2025
HILLSIDE, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- HT Vet, the veterinary health technology company behind HT Vista, the only non-invasive, first-line cancer detection tool for dogs, today announced survey results showing that veterinary practices using the …
First Atlantic Nickel Unveils Initial Phase 2 Drill Plan Map with Drilling Underway Following Phase 1 Discovery at RPM Zone Confirming First Large-Scale Awaruite in the Atlantic
GlobeNewswire
·
July 23, 2025
GRAND FALLS-WINDSOR, Newfoundland and Labrador, July 23, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce the release of its Initial Phase 2 Drill Plan Map …
4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock
GlobeNewswire
·
July 23, 2025
The trial will evaluate safety, dosing, and efficacy in patients with cardiogenic shock Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial …
UPDATE -- HT Vet Survey Reveals HT Vista’s Ability to Increase Revenue for Veterinary Clinics
GlobeNewswire
·
July 23, 2025
HILLSIDE, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- HT Vet, the veterinary health technology company behind HT Vista, the only non-invasive, first-line cancer detection tool for dogs, today announced survey results showing that veterinary practices using the …
Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
HT Vet Survey Reveals HT Vista’s Ability to Increase ROI for Veterinary Clinics
GlobeNewswire
·
July 23, 2025
HILLSIDE, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- HT Vet, the veterinary health technology company behind HT Vista, the only non-invasive, first-line cancer detection tool for dogs, today announced survey results showing that veterinary practices using the …
Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide
GlobeNewswire
·
July 23, 2025
Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology …
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire
·
July 23, 2025
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …